Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 208Lymphoid 14Other hematologic neoplasm 8Myeloid 8Sarcoma 4CNS 2Tumor-Agnostic 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × pomalidomide × Other solid neoplasm × Clear all
NCT00482521 2012-08-28

CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment

Case Comprehensive Cancer Center

Phase 1 Completed
42 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡